Literature DB >> 27003923

The role of autonomic dysfunction in cirrhotic patients before and after liver transplantation. Review of the literature.

Cristina Di Stefano1, Valeria Milazzo1, Alberto Milan1, Franco Veglio1, Simona Maule1.   

Abstract

In patients affected by hepatic cirrhosis, autonomic dysfunction is a common finding; usually it is asymptomatic but it may correlate with increased mortality and morbidity before, during and after liver transplant, due to hemodynamic instability in the course of stressful events like sepsis, gastrointestinal bleeding and reperfusion after transplantation surgery. Hyperdynamic circulation and hepatic dysfunction seem to play a role in the pathogenesis of autonomic dysfunction, even if pathophysiological mechanisms are not completely known. We present a revision of previous literature about prevalence, pathophysiological mechanisms, clinical features, and mortality and morbidity of autonomic dysfunction secondary to hepatic cirrhosis.
© 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  autonomic dysfunction; cirrhosis; liver transplantation

Mesh:

Year:  2016        PMID: 27003923     DOI: 10.1111/liv.13126

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  4 in total

1.  Cardiac autonomic modulation in children with severe liver disease, before and after liver transplantation.

Authors:  Renata Salatini; Joice Amaral; Rodrigo Daminello Raimundo; Fernando Rocha; Luiz Carlos de Abreu; Mauro Morais; Uenis Tannuri; Ana Cristina Tannuri
Journal:  Transl Pediatr       Date:  2022-04

Review 2.  Interplay of cardiovascular mediators, oxidative stress and inflammation in liver disease and its complications.

Authors:  Csaba Matyas; György Haskó; Lucas Liaudet; Eszter Trojnar; Pal Pacher
Journal:  Nat Rev Cardiol       Date:  2020-09-30       Impact factor: 32.419

Review 3.  Cholinergic Anti-Inflammatory Pathway and the Liver.

Authors:  Khalil Hajiasgharzadeh; Behzad Baradaran
Journal:  Adv Pharm Bull       Date:  2017-12-31

4.  Liver Disease as a Predictor of New-Onset Atrial Fibrillation.

Authors:  William A Huang; Eric A Dunipace; Julie M Sorg; Marmar Vaseghi
Journal:  J Am Heart Assoc       Date:  2018-08-07       Impact factor: 5.501

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.